The protein profiles of washed platelets from nine patients with essential thrombocythemia were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In four patients, an additional protein band (reduced Mr of 170,000) was clearly identified in both unstimulated platelet preparations and thrombin-released supernatant fractions. This band was also evident, though to a lesser extent, in three more patients, but it could not be located in the two remaining patients nor in any of ten controls. Subsequent characterization of the 170,000 reduced protein in one patient indicated that (a) it was glycosylated, as judged by periodic acid-Schiff staining, and (b) that native protein was a disulfide-linked multimer (possibly trimeric), which (c) partially bound to the activated platelet plasma membrane in the presence of calcium, and (d) was immune precipitated by anti-glycoprotein G antisera. The combined evidence is consistent with the 170,000 reduced protein being a modified form of the normal subunit of the platelet alpha-granule constituent, glycoprotein G (also termed thrombospondin and thrombin-sensitive protein).
gregation (4) (5) (6) , possibly due to defective stimulus-receptor coupling (7) , is often found while decreased platelet adhesiveness to glass bead columns occurs in almost all cases (4) . Deficient lipid peroxidation (8) , serotonin uptake (3, 5, 9) , lipoxygenase activity (10) , and prostaglandin D2 receptor function (1 1) have also been reported. At the molecular level, alterations in the amount of platelet membrane glycoproteins, particularly in the glycoprotein I and glycoprotein IV molecular weight regions (12, 13) , have been demonstrated by carbohydrate staining, although with no apparent correlation to the aggregation response (12) or density distribution (13) .
Glycoprotein G (14) (also termed thrombospondin [15] and thrombin-sensitive protein [16] ) is a high molecular weight glycoprotein (17) contained in the platelet a-granules (18) (19) (20) and is rapidly released on thrombin stimulation (16, 21) , along with the other a-granule constituents. It comprises -2% of total platelet protein (22) and 20-30% of releasable protein (16) . The protein is a trimer consisting of equivalent disulfide-linked subunits with M, of 185,000 as determined by the discontinuous electrophoretic system of Laemmli (23, 24) and Mr of 145,000 by the electrophoretic system of Weber and Osborn (15, 24) . Glycoprotein G contains =5% carbohydrate (16) . Binding of glycoprotein G to the activated platelet membrane surface is reported to be calcium-mediated (21), a functional property also attributed to fibrin/fibrinogen (21). Recent reports indicate that glycoprotein G is the platelet endogenous lectin (25) and that fibrinogen is the lectin receptor (26) . Binding of glycoprotein G to fibrinogen in a cell-free assay (27) is reported to be inhibited by the same aminosugars and net positively charged amino acids that specifically inhibit the enhanced lectin activity of thrombin-stimulated platelets (27, 28) . These same aminosugars and amino acids also inhibit thrombin-induced platelet aggregation (28) , suggesting that platelet membrane cohesiveness may involve the formation of lectin-lectin receptor bridging complexes (25, 28) . Immune precipitation. Thrombin supernatants from control and patient platelets (109/ml in ETS, I U/ml of a-thrombin) were labeled by lactoperoxidase-catalysed iodination (23) . Thrombin was inhibited I min after platelet stimulation by addition of2 U/ml ofhirudin. Labeled platelet supernatant (200 Al) was equilibrated with 20 Ml of a I mg/ml concentration of either nonimmune IgG or affinity-purified antiglycoprotein G for 2 h at 4°C. Immune precipitation with fixed S. aureus cells (PANSORBIN) was then performed essentially as previously described (29) .
Electrophoresis and autoradiography. Platelet samples were prepared for electrophoresis by solubilization in 2% (wt/vol) sodium dodecyl sulfate (SDS) in the absence (nonreducing) or presence (reducing) of 5% (vol/ vol) 2-mercaptoethanol. Reduced samples were heated at 100°C for 10 min and nonreduced samples at 1000C for 3 min to afford complete solubilization (30) . One-dimensional electrophoresis was performed according to the method of Laemmli (31) by using either a 5% linear of a 5-15% or 5-20% exponential gradient of acrylamide in the resolving gel and 3% acrylamide in the stacking gel. Two-dimensional (nonreducedreduced) electrophoresis was performed as previously described (23) . Sample loads were 100 Ml and contained the protein equivalent of 5 X I0' platelets: =100 Mg in the case of whole platelets, and 10 Mg for supernatants. Gels were stained for protein with Coomassie brilliant blue (32) and for glycoprotein with periodic acid-Schiff reagent (33) . Molecular weight markers were obtained from Bio-Rad Laboratories: myosin (200,000), jl-galactosidase (130,000), phosphorylase B (94,000), bovine serum albumin (68,000), ovalbumin (43,000), carbonic anhydrase (30,000), soybean trypsin inhibitor (21,500), and lysozyme (14, 400 (a) Glycoprotein G has a subunit M, of 185,000 (23) and exists as a disulfide-linked trimer (17, 23) . On SDS-polyacrylamide gel electrophoresis of a-granule proteins under nonreducing conditions, the highest molecular weight protein band is glycoprotein G (18) . When ( Fig. 2) , the 170,000 protein band no longer electrophoresed at this molecular weight (lane 2). Instead, the patient's preparation showed extra protein bands immediately below that of glycoprotein G, indicating that the 170,000 reduced protein was part of, or existed as, a disulfide-linked multimer similar to glycoprotein G. This was confirmed by two-dimensional nonreducedreduced SDS-polyacrylamide gel electrophoresis (compared with Fig. 3 d) .
(b) Both the glycoprotein G subunit and the 170,000 reduced protein stained for carbohydrate with periodic acid-Schiffreagent (patient's thrombin supernatant, reduced SDS-polyacrylamide gel electrophoresis, data not shown). (c) In the presence of the chelating agent, EDTA, all the agranule proteins are released into the supernatant. However, in the presence ofexogenous calcium ions, the released glycoprotein G and fibrinogen (or fibrin in the case ofa-thrombin) are partially bound and become major constituents of the activated platelet membrane surface (21). To determine if the 170,000 reduced protein shared this functional property, control and patient's platelets were thrombin-stimulated and pulse-radioiodinated, and then, the platelet pellets were examined by using two-dimensional nonreduced-reduced SDS-polyacrylamide gel electrophoresis, a procedure which clearly separates glycoprotein G (and fibrinogen) from the intrinsic membrane glycoproteins (18, 20) . The Coomassie blue-stained gels of unstimulated control and patient's platelets are shown in Fig. 3 a and d , respectively. The 170,000 reduced protein occurred as a distinct spot below that of the glycoprotein G subunit, confirming that both derive from disulfide-linked species of similar molecular weight. In control and patient's unstimulated platelets, only the intrinsic membrane glycoproteins were iodinated (Fig. 3 b and e, respectively). The 170,000 reduced protein was not detectable on the surface of the patient's unstimulated platelets (Fig. 3 e) which is consistent with its putative internal localization before stimulation. In control and patient's platelets aggregated with a-thrombin in the presence of exogenous calcium ions, both glycoprotein G and fibrin were present on the activated platelet surface (Fig. 3 c and f respectively) as was the 170,000 protein in the patient sample (Fig. 3f) . Control experiments confirmed that the amount of glycoprotein G and the 170,000 reduced protein bound onto the patient's stimulated platelets was greater in the presence of calcium ions than in the presence of EDTA (data not shown). The control samples in the two-dimensional gels showed a lightly labeled or stained smear in the 180,000 region below glycoprotein G, but lacked a discrete spot at 170,000 ( Fig. 3 a and c) . A broad band with reduced molecular weight of 180,000 was also observed electrophoretically with high protein loads of purified glycoprotein G and on western blots of intact platelets with antiglycoprotein G antibody (data not shown). Thus, while normal controls may contain small amounts of the 170,000 band, the levels are below the detection limit of the electrophoretic methods employed in this study.
(d) The immunological relatedness ofthe 170,000 reduced protein to glycoprotein G was tested by reacting thrombin supernatant proteins radioiodinated by lactoperoxidase with either nonimmune IgG or affinity-purified antiglycoprotein G antibody. Although some nonspecific binding of glycoprotein G and fibrin to S. aureus cells occurred in the presence of nonimmune IgG (Fig. 4, odd lanes) , antiglycoprotein G IgG specifically immune precipitated glycoprotein G (Fig. 4 , even lanes) and in the patient sample, the 170,000 reduced protein (Fig. 4,  lanes 4 and 8) . This result was confirmed on control and R.D.'s supernatants by using an immunological technique (34) based on western blotting (35) (data not shown).
Preliminary screening of eight other patients with essential thrombocythemia demonstrated the prevalence of the 170,000 reduced protein in this disorder. Electrophoretic analysis of unstimulated whole platelets (not shown) and the corresponding a-thrombin supernatants (Fig. 5) revealed that, in three patients (M.V., G.W., and H.K.), the intensity of the 170,000 reduced band was similar to or greater than that in R.D. In three more patients (C.B., A.D., and H.H., the latter two not shown in Fig.  5 ), this band was evident though with less intensity than in R.D. The 170,000 reduced band could not be identified in the remaining two patients (E.S. and A.S.), nor in any often normal controls. In the case of E.S., there appeared to be a deficiency protein in one patient, R.D., strongly suggests that it is a clipped form of platelet glycoprotein G (reduced Mr of 185,000), a disulfide-linked trimer (17, 23) which partially binds to the activated platelet surface in the presence of calcium ions (21). Glycoprotein G appears to be an a-granule protein since it is absent in platelets from patients with the Gray Platelet syndrome along with other known a-granule constituents (18) (19) (20) . The present data suggests that the 170,000 reduced protein is also an a-granule constituent since it could not be labeled on the unstimulated platelet surface (Fig. 3) , but appeared in the supernatant on thrombin stimulation (Fig. 1) . The 170,000 reduced protein was part of, or existed as a disulfide-linked multimer (Figs. 2 and 3 ) and was partially bound to the activated platelet surface in the presence of exogenous calcium ions (Fig. 3) . Furthermore, the 170,000 reduced protein is immune-precipitated by antiglycoprotein G antibody (Fig. 4) . The combined evidence is consistent with this protein being a clipped form ofthe normal subunit of glycoprotein G.
While the 170,000 reduced protein appears to be prevalent in patients with essential thrombocythemia (Fig. 5) , the ratio of glycoprotein G to the clipped form varied widely (almost 1:1 in the case of H.K. to 6.5:1 in the case of C.B., as judged by scanning densitometry of Coomassie blue-stained gels of athrombin supernatants). In the case of R.D., staining for protein by Coomassie blue (Fig. 1) and for carbohydrates by periodic acid-Schiff reagent indicated a ratio of -2:1 (by densitometry), whereas the immune precipitation data (Fig. 4) and a comparison of counts associated with ['25I]-labeled thrombin supernatant proteins suggested a ratio closer to 1:1. While the pattern of four bands in the nonreduced gel (Fig. 2, lane 2) could derive from either of these ratios together with a random disulfidelinked assembly of 185,000 and 170,000 subunits, the intensity of staining is more consistent with a 2:1 ratio. The discrepancy between the labeling and staining results presumably reflects an increased exposure of tyrosine residues in the clipped subunit. The 170,000 reduced protein could be demonstrated in R.D.'s platelets on all occasions studied over a 2-yr period, and in G.W.'s platelets over a 6-mo period, while the intensity of this band relative to glycoprotein G remained constant during these periods of time.
Several possibilities exist as to the origin and nature of the 170,000 reduced protein. It could derive from a transcriptional defect, or alternatively, a posttranscriptional modification of the parent molecule involving either a glycosylation defect or proteolytic clipping. Staining of the 170,000 reduced protein with periodic acid-Schiffreagent suggested that a glycosylation defect is unlikely. If proteolysis is the case, then it must occur either in the a-granules or before assembly of a-granule constituents since the clipped form is present in unstimulated platelets (Fig.  1) . In support of this, prolonged incubation of glycoprotein G with thrombin (4 U/ml) in the presence of calcium has been reported to hydrolyze the 185,000 subunit to a 160,000 cleavage product (24) .
The apparent molecular weight clip of 15,000 (reduced) did not appear to affect calcium-dependent binding of modified glycoprotein G to activated platelets (Fig. 3) . Preliminary experiments to characterize a functional consequence of the observed cleavage have been equivocal. Patients H.K. and G.W. had normal levels of thrombin-enhanced platelet-bound and supernatant lectin activities (25, 36) . Neither glycoprotein G nor a thrombin-generated proteolytic mixture of 170,000 and 140,000 (reduced) derivatives of glycoprotein G (24) had any effect on platelet aggregation induced by threshold or higher concentrations ofADP, collagen, or epinephrine. While the role ofglycoprotein G in platelet function is not yet clear, the reported binding to fibrinogen (27) , possibly via a lectin-binding site, suggests a role in platelet cohesion (25, 28) . It remains possible that one or more ofthese binding sites may be absent or altered in the modified protein, resulting in a form which may impede normal function. The inability in preliminary experiments to observe a functional consequence of cleavage may be due to the concentration disadvantage of exogenous vs. endogenous released glycoprotein. Glycoprotein G has recently been reported to also be synthesized by endothelial cells (37) and fibroblasts (38) . Whether these cells from patients with essential thrombocythemia also produce a modified form of glycoprotein G and whether this altered form in platelets correlates with the reported functional abnormalities in this disorder is under current investigation.
